(Total Views: 421)
Posted On: 06/30/2022 12:24:29 PM
Post# of 148878
Novo Nordisk's NASH drug is WORSE than placebo -- yet they say it's "on track. "
https://www.fiercepharma.com/pharma/after-pha...-fail-nash
Quote:
In the study of 71 NASH patients with compensated cirrhosis (the F4 stage of the disease), only 10.6% of those who received a weekly 2.4 mg dose of semaglutide saw an improvemen t in liver fibrosis coinciding with no worsening of NASH. The figure for those on placebo was 29.2%.
As a secondary endpoint, 34% of patients on semaglutide saw a resolution of NASH—which means improvement in liver inflammation and liver cell ballooning—versus 20.8% on placebo.
https://www.fiercepharma.com/pharma/after-pha...-fail-nash
(4)
(0)Scroll down for more posts ▼
